CEO, Hang-Cheol Shin, PhD

CEO Hang-Cheol Shin, PhD has been working in the field of biomedicinal R&D for more than 30 years since his PhD at the University of Sydney, followed by working as a researcher at The Scripps Research Institute, Cornell University, and an assistant professor at Endocrinology Research Institute, Yonsei University College of Medicine. He started working as a protein engineering group leader at the Hanhyo Institute of Technology in 1991 and successfully pioneered biobetter engineering through the development of engineered human recombinant proteins such as TNF-α and insulin.

In 2001, he joined Soongsil University as a professor and has continued his career as a professor for over 20 years during which he demonstrated his academic excellence through numerous research articles, conference presentations, and patents on protein structure and engineering fields. He is acknowledged as one of the pioneers in Korea for protein engineering of biomedicine.

In 2011, he founded PnP Biopharm. In his years at PnP Biopharm, he successfully developed human growth factors with improved stability and activity. PnP Biopharm became a major provider of growth factors to domestic and global business partners as essential cosmeceutical ingredients, mostly due to his ceaseless effort in business development and partnering with various companies. He is currently expanding the capability of PnP Biopharm to growth factor-based medicines, nanobody development for anticancer therapeutics and diagnostics, and culture media for stem cells and exosome production as well.